CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH OR WITHOUT METABOLIC SYNDROME

被引：0
|
作者：
Millan, J. [1 ]
Garcia Calzado, C. [2 ]
Recarte, C. [3 ]
机构：
[1] Hosp GU Gregorio Maranon, Madrid, Spain
[2] Univ Cadiz, Cadiz, Spain
[3] Univ Complutense, E-28040 Madrid, Spain
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2011年 / 12卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(11)70127-1
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
126
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [1] Cardiovascular risk in patients with diabetes type 2 with or without associated metabolic syndrome
    Munoz Roldan, Inmaculada
    Martin Puig, Maria Belen
    Agudo Villa, Maria Teresa
    Garcia Andrade, Carlos Recarte
    Millan Nunez-Cortes, Jesus
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2011, 23 (03): : 112 - 118
  • [2] The cardiovascular risk in patients with type 1 diabetes mellitus and metabolic syndrome
    Timar, R. Z.
    Serban, V.
    Diaconu, L.
    Botea, V.
    Vlad, A.
    Sima, A.
    Rosu, M.
    [J]. DIABETOLOGIA, 2006, 49 : 228 - 229
  • [3] Cardiovascular risk assessment in patients with type 2 diabetes mellitus and metabolic syndrome: Role of biomarkers
    Kanbak, Gungor
    Akalin, Aysen
    Dokumacioglu, Ali
    Ozcelik, Eda
    Bal, Cengiz
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2011, 5 (01) : 7 - 11
  • [4] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152
  • [5] Prevalence of cardiovascular risk factors and metabolic syndrome in patients with type 2 diabetes mellitus in cardiac rehab
    Blanc, Philippe
    Boussuges, Alain
    Maunier, Sebastien
    Chopra, Soeb
    Debussche, Xavier
    [J]. DIABETES, 2007, 56 : A589 - A589
  • [6] Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes
    Orna, JAG
    Arnal, LML
    Herguedas, EM
    Julián, BB
    Córdoba, DPP
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (06): : 507 - 513
  • [7] THE metabolic syndrome and accurate cardiovascular risk prediction in persons with type 2 diabetes mellitus
    Ipadeola, A.
    Adeleye, J. O.
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2016, 10 (01) : 7 - 12
  • [8] Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk
    Stalenhoef, A. F. H.
    Davidson, M. H.
    Robinson, J. G.
    Burgess, T.
    Duttlinger-Maddux, R.
    Kallend, D.
    Goldberg, A. C.
    Bays, H.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (01): : 30 - 39
  • [9] Canagliflozin improves risk factors of metabolic syndrome in patients with type 2 diabetes mellitus and metabolic syndrome
    Davies, Michael J.
    Merton, Katherine W.
    Vijapurkar, Ujjwala
    Balis, Dainius A.
    Desai, Mehul
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 47 - 55
  • [10] Metabolic syndrome in Type 1 and Type 2 diabetes mellitus and its association with high cardiovascular risk
    Reddy, H.
    Gopinath, A.
    Morrissey, J.
    Patel, V.
    [J]. DIABETIC MEDICINE, 2007, 24 : 55 - 56
12345